Johanna A. Higgins
University of Oklahoma
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Johanna A. Higgins.
European Journal of Nuclear Medicine and Molecular Imaging | 2007
John P. Higgins; Johanna A. Higgins; Gethin Williams
IntroductionCertain stress-induced ancillary findings on myocardial perfusion scintigraphy increase the likelihood that the patient has coronary artery disease (CAD); furthermore, among CAD patients, they indicate more severe and extensive disease, placing these patients at higher risk for future cardiac events. Indeed, in studies with no obvious perfusion defect yet with serious CAD—for example, balanced ischemia—it can be these high-risk findings that necessitate invasive intervention.DiscussionBesides reversible perfusion defects, such findings include increased pulmonary radiotracer uptake, transient cavity dilatation, increased end-diastolic or end-systolic volume, decreased post-stress ejection fraction, and increased right ventricular tracer uptake on stress images. The pathophysiology underlying these findings is clearly different as they do not always occur together, and each independently predicts more severe and extensive CAD. In the current review, these findings are defined and their significance in diagnosing patients with suspected or known CAD is discussed.
Expert Review of Cardiovascular Therapy | 2003
John P. Higgins; Johanna A. Higgins; Patricia M Higgins; Samir Ahuja; Daniel L Higgins
Chlamydia pneumoniae (Cp) infection in early life may accelerate atherosclerosis over ensuing decades, leading to cardiovascular complications. Cp promotes endothelial dysfunction and may modulate inflammation underlying atherosclerosis. It represents a biologically plausible candidate for the causation of atherosclerosis. Other infections simultaneously occurring with Cp may result in a synergistic effect to promote atherosclerosis. Studies on the treatment of Cp with antibiotics indicates decreased rates of infection, modulation of inflammation and in some settings, fewer cardiovascular complications.
Clinical and Investigative Medicine | 2003
John P. Higgins; Johanna A. Higgins
Journal of Epidemiology | 2003
John P. Higgins; Johanna A. Higgins
American Heart Journal | 2006
John P. Higgins; Gethin Williams; James S. Nagel; Johanna A. Higgins
International Journal of Cardiology | 2007
John P. Higgins; Johanna A. Higgins
American Heart Journal | 2010
John P. Higgins; Troy Tuttle; Johanna A. Higgins
The Journal of the Oklahoma State Medical Association | 2002
John P. Higgins; Johanna A. Higgins
/data/revues/00028703/v159i1/S0002870309008266/ | 2011
John P. Higgins; Troy Tuttle; Johanna A. Higgins
The Journal of the Oklahoma State Medical Association | 2003
John P. Higgins; Johanna A. Higgins